Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances

Daily Values

Growth Metrics

IGC Pharma (IGC) Net Cash Flow (2016 - 2025)

IGC Pharma has reported Net Cash Flow over the past 16 years, most recently at $646000.0 for Q3 2025.

Quarterly Net Cash Flow rose 341.95% to $646000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$473000.0 through Sep 2025, up 67.91% year-over-year, with the annual reading at -$786000.0 for FY2025, 60.54% up from the prior year.
Net Cash Flow was $646000.0 for Q3 2025 at IGC Pharma, up from $24000.0 in the prior quarter.
Over five years, Net Cash Flow peaked at $13.6 million in Q1 2021 and troughed at -$2.5 million in Q4 2021.
The 5-year median for Net Cash Flow is -$1.1 million (2024), against an average of $12052.6.
The largest YoY upside for Net Cash Flow was 583.14% in 2021 against a maximum downside of 1194.24% in 2021.
A 5-year view of Net Cash Flow shows it stood at -$2.5 million in 2021, then skyrocketed by 32.65% to -$1.7 million in 2022, then grew by 0.96% to -$1.6 million in 2023, then skyrocketed by 34.75% to -$1.1 million in 2024, then soared by 160.04% to $646000.0 in 2025.
Per Business Quant, the three most recent readings for IGC's Net Cash Flow are $646000.0 (Q3 2025), $24000.0 (Q2 2025), and -$67000.0 (Q1 2025).